Navigation Links
Vanda Pharmaceuticals Files Shelf Registration Statement
Date:1/31/2011

ROCKVILLE, Md., Jan. 31, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that it has filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). Upon being declared effective by the SEC, the shelf registration statement will allow the Company to offer and sell, from time to time, up to $50 million of common stock, preferred stock, debt securities, warrants, or any combination thereof in one or more future public offerings. The actual amount and type of securities, or combination of securities, and the terms of those securities, will be determined at the time of sale, if such sale occurs. If and when a particular series of securities is offered, the prospectus supplement relating to that offering will set forth Vanda's intended use of the net proceeds received from the sale of those securities.

The filing of the shelf registration statement is designed to provide Vanda with greater flexibility to take advantage of acquisition, financing and other business opportunities when and if such opportunities arise. As of the date of this release, Vanda has no specific plans to issue securities under the shelf registration statement, and is not required to offer any securities in the future.

The shelf registration statement has not yet become effective. The securities offered by Vanda under the shelf registration statement may not be sold nor may offers to buy be accepted before the time the shelf registration statement becomes effective, nor may sales be effected in the absence of a definitive prospectus and a prospectus supplement setting forth the terms and conditions of any specific offering of securities.

This press release shall not constitute an of
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... A team of Chinese and US scientists has determined ... plays a critical role in thrombosis, or blood clot, ... which challenge the conventional concepts of drug action at ... for future drug discovery. In a paper ... researchers at Shanghai Institute of Materia Medica ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... addition of the "Marine Biotechnology - Global ... Annual estimates and forecasts are provided ... seven-year historic analysis is provided for these markets. ... and secondary research. This report analyzes ...
(Date:3/30/2015)... , March 30, 2015  Orexigen Therapeutics, ... Tom Cannell has joined as Chief ... commercialization of Contrave® /Mysimba™ (naltrexone HCl / bupropion ... of Orexigen,s global commercial strategy, assuming responsibilities previously ... leading Orexigen,s commercial effort through the U.S. launch ...
Breaking Medicine Technology:New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10
... Corporation (Nasdaq: LMNX ) announced today ... the discovery of novel biomarkers and development of ... Center for Personalized Genetic Medicine (PCPGM) to develop ... within Partners HealthCare entities.  These innovative tests will ...
... 15, 2011 Cayenne Medical, Inc., a private sports ... its second generation soft tissue repair device for multi-ligament ... at the 2011 American Academy of Orthopaedic Surgeons (AAOS) ... Key to AperFix II is the introduction of its ...
Cached Medicine Technology:Luminex and Partners HealthCare Announce Collaboration Agreement 2Luminex and Partners HealthCare Announce Collaboration Agreement 3Cayenne Medical, Inc. Launches AperFix® II 2
(Date:3/30/2015)... 2015 V/NO (Virtually No Alcohol) Wines have ... for opening/closing and for reuse. Consumers simply twist the cup, ... New Yorkers, professionals, and basically anyone can now enjoy a ... kick back socially or pair with meals at work, home, ... dealcoholized wine and that means Napa Wine grapes undergo ...
(Date:3/30/2015)... 2015 The “Orthopedic Software ... Orthopedic PACS) By Applications (Orthopedic Surgery, Joint ... of Delivery] – Global Forecast to 2020” ... and opportunities in North America, Europe, Asia-Pacific ... , Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 ...
(Date:3/30/2015)... Software applications from five global software ... AS4 test and certification event, announced today by ... software testing. New software applications from Axway, Flame ... this vendor-neutral test event which began in 3Q14. ... for IBM, Oracle and Software AG, joining re-certifications ...
(Date:3/30/2015)... 30, 2015 People from all walks of ... of meditation -- yet want a refreshingly simple and easy ... with the new app MindBody Sessions. The app can be ... http://www.mindbodysessions.com , or it can be downloaded for mobile devices ... . , Developed by MindBody Sessions LLC, the app ...
(Date:3/30/2015)... March 30, 2015 Corra Group is continuing ... the needs of every industry that requires this form of ... mandates or seek new ways to increase productivity and cut ... panels that will help detect substance abuse with a wide ... drug tests,” said Corra Group Co-Founder, Gordon Basichis. ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3Health News:New Web, iOS and Android App “MindBody Sessions” Makes Mindfulness and Meditation Easy 2Health News:New Web, iOS and Android App “MindBody Sessions” Makes Mindfulness and Meditation Easy 3Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3
... Inc. (http://www.leViv.com ), the,only company focused exclusively ... launched five innovative programs today. The new,programs include ... 2 snacks,per day -- over 110 items in ... resources, professional advice,news, health information and more., ...
... 9 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,MDZ), ... the global life,sciences markets, today announced that it ... notice of arbitration proceedings. MDS will be,seeking an ... obligations,under its 2006 interim and long-term supply agreement ...
... content on breastfeeding with, the ,Breastfeeding.com Answer ... from allergies and infections to growing pains ... 9 Breastfeeding.com, a premier,online resource with ... already,unparalleled content on breastfeeding with over 1400 ...
... premier international surgical and medical equipment supplier, reminds its customers that ... on 2008 income tax filings. , ... Louisville, KY ... in accordance with Tax Code Section 179, can strengthen buying power ...
... Diamond Elite Walk In Tub is thicker, stronger, and warranted not ... ... July 9, 2008 -- After two years in development, The Kitchen Bath ... tubs: Diamond Elite Walkin Tubs . This premier walk-in tub has ...
... leader in online insurance data and free rate quotes ... help voters understand the position presidential candidates are taking ... which is advertisement-free, supplies unbiased material on medical, auto, ... the best choices in coverage for themselves and their ...
Cached Medicine News:Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: